Two cases of metastatic colorectal cancer with prolonged liver injury following capecitabine combination chemotherapy-Reference-Cited by-同舟云学术

Two cases of metastatic colorectal cancer with prolonged liver injury following capecitabine combination chemotherapy

Published:2024-07 Issue:7 Volume:17 Page:e260012
ISSN:1757-790X
Container-title:BMJ Case Reports
language:en
Short-container-title:BMJ Case Rep

Author:

Takada Takahiro^ORCID,Katoh Ryuji,Yamada Kazunosuke,Ojima Hitoshi

Abstract

We present two cases of metastatic colorectal cancer where a liver injury developed while receiving capecitabine. In both cases, the patients were switched from oral capecitabine to a continuous intravenous 5-fluorouracil infusion and were able to continue treatment without a relapse of hepatotoxicity.

Publisher

BMJ

Reference15 articles.

1. Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

2. Comparison of oral Capecitabine versus intravenous fluorouracil plus Leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study;Hoff;J Clin Oncol,2001

3. Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial

4. Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

5. Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capecitabine;Reactions Weekly;2024-08-17